PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2454289.24%
10Y revenue/share CAGR above 1.5x NHC.AX's 356.89%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
3243.04%
5Y revenue/share CAGR above 1.5x NHC.AX's 91.95%. David Dodd would look for consistent product or market expansions fueling outperformance.
66.54%
3Y CAGR of 66.54% while NHC.AX is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
160.42%
OCF/share CAGR of 160.42% while NHC.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
184.59%
Below 50% of NHC.AX's 885.17%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-41.57%
Negative 3Y OCF/share CAGR while NHC.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
74.81%
Net income/share CAGR above 1.5x NHC.AX's 6.83% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-130.87%
Negative 5Y net income/share CAGR while NHC.AX is 315.45%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-165.21%
Negative 3Y CAGR while NHC.AX is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-103.80%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-6.15%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-258.04%
Negative 3Y equity/share growth while NHC.AX is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.